Skip to content
BidBenchmark

Contract award

AMNEAL PHARMACEUTICALS OF NEW YORK, LLC

PHARMACEUTICAL - XYREM (SODIUM OXYBATE) - 2026 PRICE INCREASE & DOSAGE USED.
PIID
36C26026F0059
Award key
CONT_AWD_36C26026F0059_3600_36F79722D0161_3600
Recipient UEI
LVEBAQTPN615
Parent award
3600
Source as of
Aug 6, 2026
Current award value
$319,3993
Obligated to date
$319,3992
Potential with options
$319,3993
Awarding agency
Department of Veterans AffairsDepartment of Veterans Affairs
Place of performance
Brookhaven, New York
Set-aside
None
Pricing
FIRM FIXED PRICE
Competition
3 offers received
Period of performance
Nov 1, 2025Oct 31, 2026Through Oct 31, 2026 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
P00002Mar 6, 2026FUNDING ONLY ACTION$7,927.02$319,399.02

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585
contractor_idUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585
current_award_valueUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585
naics_codeUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585
potential_award_valueUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585
psc_codeUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585
total_obligatedUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.224edb1916585

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov (FY2026_All_Contracts_Full_20260807_2.csv), retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
36C26026F0059 — AMNEAL PHARMACEUTICALS OF NEW YORK, LLC · BidBenchmark